{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:28:01Z","timestamp":1789421281786,"version":"build-2803163510"},"reference-count":54,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,25]],"date-time":"2006-01-25T00:00:00Z","timestamp":1138147200000},"content-version":"vor","delay-in-days":1607,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2001,9]]},"abstract":"<jats:p><jats:bold>A<jats:sc>bstract<\/jats:sc>: <\/jats:bold> Mycosis fungoides and its leukemic variant, S\u00e9zary syndrome, represent the most common forms of cutaneous T cell lymphomas (CTCL). These disorders are clonal neoplasms characterized by the progressive accumulation of cells that resemble activated\/memory CD4<jats:sup>+<\/jats:sup> T cells. Unlike their normal counterparts, these malignant lymphocytes have prolonged life spans and are resistant to dying following treatment with most chemotherapeutic agents. This suggests that CTCL undergo abnormal programmed cell death; however, data regarding apoptotic defects in CTCL are limited. Regulation of apoptosis in lymphocytes that regularly undergo clonal expansion is necessarily complex and will be reviewed here. Clonally expanded lymphocytes rely primarily on Fas\u2010mediated pathways to initiate apoptosis. Factors leading to the resistance of apoptosis in CTCL and new therapeutic approaches for reversing this resistance will be discussed, including the important role that the Fas death pathway may play in the pathogenesis and treatment of CTCL.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2001.tb03710.x","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T23:22:30Z","timestamp":1279668150000},"page":"46-58","source":"Crossref","is-referenced-by-count":33,"title":["Reversible Resistance to Apoptosis in Cutaneous T Cell Lymphoma"],"prefix":"10.1111","volume":"941","author":[{"given":"SANDRA J.","family":"MEECH","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RICHARD","family":"EDELSON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PATRICK","family":"WALSH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DAVID A.","family":"NORRIS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RICHARD C.","family":"DUKE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,1,25]]},"reference":[{"key":"e_1_2_11_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/scientificamerican1296-80"},{"key":"e_1_2_11_3_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.132.1.38"},{"key":"e_1_2_11_4_2","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.4049\/jimmunol.148.7.2207","article-title":"Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages","volume":"48","author":"Fadok V.A.","year":"1992","journal-title":"J. Immunol."},{"key":"e_1_2_11_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90422-0"},{"key":"e_1_2_11_6_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.281.5381.1312"},{"key":"e_1_2_11_7_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.281.5381.1305"},{"key":"e_1_2_11_8_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.281.5381.1309"},{"key":"e_1_2_11_9_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/16.20.6200"},{"key":"e_1_2_11_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81590-1"},{"key":"e_1_2_11_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/17.6.1675"},{"key":"e_1_2_11_12_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.281.5381.1322"},{"key":"e_1_2_11_13_2","first-page":"1440","article-title":"Involvement of the bcl\u20102 gene in human follicular lymphoma","volume":"288","author":"Tsujimoto Y.","year":"1985","journal-title":"Nature"},{"key":"e_1_2_11_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-9525(00)89010-1"},{"key":"e_1_2_11_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/40657"},{"key":"e_1_2_11_16_2","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.4049\/jimmunol.163.3.1315","article-title":"Primed T cells are more resistant to Fas\u2010mediated activation\u2010induced cell death than naive T cells","volume":"163","author":"Inaba M.","year":"1999","journal-title":"J. Immunol."},{"key":"e_1_2_11_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80566-X"},{"key":"e_1_2_11_18_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.17.10376"},{"key":"e_1_2_11_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(92)90123-T"},{"key":"e_1_2_11_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/359554a0"},{"key":"e_1_2_11_21_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.281.5381.1317"},{"key":"e_1_2_11_22_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.280.5361.243"},{"key":"e_1_2_11_23_2","first-page":"289","article-title":"IL\u20102 addiction: withdrawal of growth factor activates a suicide program in dependent T cells","volume":"5","author":"Duke R.C.","year":"1986","journal-title":"Lymphokine Res."},{"key":"e_1_2_11_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.1999.tb01322.x"},{"key":"e_1_2_11_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/373441a0"},{"key":"e_1_2_11_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/373444a0"},{"key":"e_1_2_11_27_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7533326"},{"key":"e_1_2_11_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1195-294"},{"key":"e_1_2_11_29_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7539157"},{"key":"e_1_2_11_30_2","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.4049\/jimmunol.158.10.4602","article-title":"Regulation of CD95 (Fas) ligand expression by TCR\u2010mediated signaling events","volume":"158","author":"Latinis K.M.","year":"1997","journal-title":"J. Immunol."},{"key":"e_1_2_11_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830250925"},{"key":"e_1_2_11_32_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.11.5778"},{"key":"e_1_2_11_33_2","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood.V88.4.1383.bloodjournal8841383","article-title":"S\u00e9zary syndrome T\u2010cell clones display T\u2010helper 2 cytokines and express the accessory factor\u20101 (interferon\u2010gamma receptor beta\u2010chain)","volume":"88","author":"Dummer R.","year":"1996","journal-title":"Blood"},{"key":"e_1_2_11_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1995.tb03438.x"},{"key":"e_1_2_11_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb08667.x"},{"key":"e_1_2_11_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1995.tb02488.x"},{"key":"e_1_2_11_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.1997.tb01319.x"},{"key":"e_1_2_11_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.1995.tb00733.x"},{"key":"e_1_2_11_39_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01773.x"},{"key":"e_1_2_11_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12329711"},{"key":"e_1_2_11_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1991.tb33446.x"},{"key":"e_1_2_11_42_2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.140.1.171"},{"key":"e_1_2_11_43_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/36.12.1276"},{"key":"e_1_2_11_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(00)80054-4"},{"key":"e_1_2_11_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(05)70155-8"},{"key":"e_1_2_11_46_2","first-page":"15","article-title":"Treatment of cutaneous T cell lymphoma with retinoids","volume":"7","author":"Zackheim H.S.","year":"1998","journal-title":"Dermatol. Ther."},{"key":"e_1_2_11_47_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-121-8-199410150-00007"},{"key":"e_1_2_11_48_2","first-page":"16","article-title":"Pathogenesis of cutaneous T\u2010cell lymphoma: implications for the use of recombinant cytokines and photopheresis","volume":"107","author":"Rook A.H.","year":"1997","journal-title":"Clin. Exp. Immunol."},{"key":"e_1_2_11_49_2","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1182\/blood.V94.3.902.415k23_902_908","article-title":"Interleukin\u201012 therapy of cutaneous T\u2010cell lymphoma induces regression and cytotoxic T\u2010cell responses","volume":"94","author":"Rook A.H.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_11_50_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.131.5.574"},{"key":"e_1_2_11_51_2","first-page":"457","article-title":"The biochemistry and molecular biology of glucocorticoid\u2010induced apoptosis in the immune system","volume":"51","author":"Cidlowski J.A.","year":"1996","journal-title":"Recent Prog. Horm. Res."},{"key":"e_1_2_11_52_2","unstructured":"Meech S.J. R. Edelson R.C. Duke et al.2000. Malignant T cells derived from patients with leukemic CTCL demonstrate a profound but reversible defect in Fas mediated activation induced cell death (AICD). Submitted."},{"key":"e_1_2_11_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3083.1986.tb01942.x"},{"key":"e_1_2_11_54_2","doi-asserted-by":"publisher","DOI":"10.1038\/364806a0"},{"key":"e_1_2_11_55_2","first-page":"611","article-title":"Phase Ib trial of bryostatin in patients with refractory malignancies","volume":"4","author":"Grant S.","year":"1998","journal-title":"Clin. Cancer Res."}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2001.tb03710.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2001.tb03710.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T15:31:16Z","timestamp":1695655876000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2001.tb03710.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["10.1111\/j.1749-6632.2001.tb03710.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2001.tb03710.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}